These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2521223)

  • 1. Increase in H-Y antigen-positive lymphocytes in hirsute women: effects of cyproterone acetate and estradiol treatment.
    Amice V; Bercovici JP; Nahoul K; Hatahet MH; Amice J
    J Clin Endocrinol Metab; 1989 Jan; 68(1):58-62. PubMed ID: 2521223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
    Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism].
    Pugeat M; Nicolas MH; Déchaud H; Elmidani M
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1057-62. PubMed ID: 1839798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17 beta-estradiol.
    Jasonni VM; Bulletti C; Naldi S; Di Cosmo E; Cappuccini F; Flamigni C
    Fertil Steril; 1991 Apr; 55(4):742-5. PubMed ID: 1826278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.
    Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
    Jones DB; Ibraham I; Edwards CR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol].
    Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P
    Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
    Salva P; Morer F; Ordoñez J; Rodriguez J
    Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone-estradiol binding globulin (TeBG) in hirsute patients treated with cyproterone acetate (CPA) and percutaneous estradiol.
    Vincens M; Mercier-Bodard C; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem; 1989 Oct; 33(4A):531-4. PubMed ID: 2530403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
    Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
    Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mechanism of action of cyproterone acetate in the treatment of hirsutism].
    Rigaud C; Vincens M; Mowszowicz I; Wright F; Mavier P; Nahoul K; Guillemant S; Kuttenn F; Mauvais-Jarvis P
    Ann Endocrinol (Paris); 1983; 44(6):387-92. PubMed ID: 6234849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
    Garner PR; Poznanski N
    J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiandrogen-estrogen treatment on sexual and endocrine parameters in hirsute women.
    Adamopoulos DA; Kampyli S; Georgiacodis F; Kapolla N; Abrahamian-Michalakis A
    Arch Sex Behav; 1988 Oct; 17(5):421-9. PubMed ID: 2975482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian and adrenal contributions to peripheral androgens in hirsute women.
    Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
    Obstet Gynecol; 1975 Aug; 46(2):169-73. PubMed ID: 125398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen metabolism in hirsute patients treated with cyproterone acetate.
    Mowszowicz I; Wright F; Vincens M; Rigaud C; Nahoul K; Mavier P; Guillemant S; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem; 1984 Mar; 20(3):757-61. PubMed ID: 6231428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.